Bridgit Crews, PhD
Associate Professor, Pathology & Immunology
- Phone: 314-273-6201
- Email: bridgit@nospam.wustl.edu
Division
- Laboratory & Genomic Medicine
Additional Titles
- Medical Director of Mass Spectrometry and Clinical Toxicology
Education
- BA, Chemistry: University of California Davis (2001)
- PhD, Chemistry: University of California Santa Barbara (2007)
- Postdoctoral Research Fellow: The Scripps Center for Mass Spectrometry and Metabolomics, La Jolla, California (2008)
- Fellowship, Clinical Chemistry: Washington University School of Medicine, St. Louis, Missouri (2013)
Board Certifications
Diplomate, American Board of Clinical Chemistry: Chemistry (2013), Toxicology (2016)
Clinical Interests
- Clinical Mass Spectrometry Applications
- Therapeutic Drug Monitoring
- Urine Drug Testing
- Endocrinology
Research Interests
My research focuses on the development and clinical application of mass spectrometry (MS) technologies, including liquid chromatography tandem MS, high-resolution MS, and inductively coupled plasma MS to detect and quantify drugs, steroid hormones, metals, and other clinically relevant biomarkers that may be used to diagnose or monitor disease.
Selected Publications
| Commentary. Crews BO. Clin Chem. 2018 Sep;64(9):1294-1295. doi: 10.1373/clinchem.2017.286161.PMID: 30154198 |
| A Patient in Need of a Red Cell Exchange? Perez-Alvarez I, Crews BO, Woo JS, Rezk S, Tran MH. J Appl Lab Med. 2021 Jul 7;6(4):1057-1061. doi: 10.1093/jalm/jfaa159.PMID: 33241416 |
| Advances in detection of hemoglobinopathies. Greene DN, Vaughn CP, Crews BO, Agarwal AM. Clin Chim Acta. 2015 Jan 15;439:50-7. doi: 10.1016/j.cca.2014.10.006. Epub 2014 Oct 12. |
| A Striking Contrast. Mkhikian H, Crews BO. Clin Chem. 2018 Aug;64(8):1265-1266. doi: 10.1373/clinchem.2017.284224.PMID: 30054304 |
| Age- and Sex-Associated Variations in the Sensitivity of Serological Tests Among Individuals Infected With SARS-CoV-2. Vashisht R, Patel A, Crews BO, Garner OB, Dahm L, Wilson C, Butte AJ.JAMA Netw Open. 2021 Feb 1;4(2):e210337. doi: 10.1001/jamanetworkopen.2021.0337.PMID: 33576815 |
| Data-driven quality assurance to prevent erroneous test results. Crews BO, Drees JC, Greene DN.Crit Rev Clin Lab Sci. 2019 Nov 2:1-15. doi: 10.1080/10408363.2019.1678567. Online ahead of print.PMID: 31680585 |
| The Lines That Held Us: Assessing Racial and Socioeconomic Disparities in SARS-CoV-2 Testing. Hsiao CJ, Patel AGM, Fasanya HO, Stoffel MR, Beal SG, Winston-McPherson GN, Campbell ST, Cotten SW, Crews BO, Kuan K, Lapedis CJ, Mathias PC, Peck Palmer OM, Greene DN.J Appl Lab Med. 2021 Sep 1;6(5):1143-1154. doi: 10.1093/jalm/jfab059.PMID: 34240171 |
| Infection prevention strategies are highly protective in COVID-19 units while main risks to healthcare professionals come from coworkers and the community. Gohil SK, Quan KA, Madey KM, King-Adelsohn S, Tjoa T, Tifrea D, Crews BO, Monuki ES, Khan S, Schubl SD, Bittencourt CE, Detweiler N, Chang W, Willis L, Khusbu U, Saturno A, Rezk SA, Figueroa C, Jain A, Assis R, Felgner P, Edwards R, Hsieh L, Forthal D, Wilson WC, Stamos MJ, Huang SS.Antimicrob Resist Infect Control. 2021 Nov 22;10(1):163. doi: 10.1186/s13756-021-01031-5.PMID: 34809702 |
| Recent trends in designer drug abuse. Crews BO, Petrie MS.Clin Chem. 2015 Jul;61(7):1000-1. doi: 10.1373/clinchem.2015.240416.PMID: 26322357 |
| Evaluation of Commercially Available High-Throughput SARS-CoV-2 Serologic Assays for Serosurveillance and Related Applications. Stone M, Grebe E, Sulaeman H, Di Germanio C, Dave H, Kelly K, Biggerstaff BJ, Crews BO, Tran N, Jerome KR, Denny TN, Hogema B, Destree M, Jones JM, Thornburg N, Simmons G, Krajden M, Kleinman S, Dumont LJ, Busch MP.Emerg Infect Dis. 2022 Mar;28(3):672-683. doi: 10.3201/eid2803.211885.PMID: 35202525 |
Assistant
Susan Keen
keen@wustl.edu
314-273-8136